0001209191-19-025397.txt : 20190419 0001209191-19-025397.hdr.sgml : 20190419 20190419170703 ACCESSION NUMBER: 0001209191-19-025397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190417 FILED AS OF DATE: 20190419 DATE AS OF CHANGE: 20190419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neff Thomas B CENTRAL INDEX KEY: 0001623238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 19758257 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-17 0 0000921299 FIBROGEN INC FGEN 0001623238 Neff Thomas B C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 1 1 0 0 Chief Executive Officer Common Stock 2019-04-17 4 M 0 6834 2.90 A 2550176 D Common Stock 2019-04-17 4 S 0 14836 46.60 D 2535340 D Common Stock 2019-04-17 4 S 0 3464 47.17 D 2531876 D Common Stock 2019-04-17 4 S 0 100 48.75 D 2531776 D Common Stock 2019-04-17 4 S 0 1318 46.60 D 68444 I By Family Partnership Common Stock 2019-04-17 4 S 0 100 47.09 D 68344 I By Family Partnership Common Stock 2019-04-18 4 M 0 6834 2.90 A 2538610 D Common Stock 2019-04-18 4 S 0 3217 45.69 D 2535393 D Common Stock 2019-04-18 4 S 0 8625 46.82 D 2526768 D Common Stock 2019-04-18 4 S 0 6558 47.34 D 2520210 D Common Stock 2019-04-18 4 S 0 200 45.33 D 68144 I By Family Partnership Common Stock 2019-04-18 4 S 0 1218 47.13 D 66926 I By Family Partnership Common Stock 20000 I By Spouse Common Stock 60946 I See footnote Stock Option (Right to Buy) 2.90 2019-04-17 4 M 0 6834 0.00 D 2020-06-09 Common Stock 6834 293880 D Stock Option (Right to Buy) 2.90 2019-04-18 4 M 0 6834 0.00 D 2020-06-09 Common Stock 6834 287046 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $46.01 to $46.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $47.00 to $47.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $46.07 to $46.8775. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $45.18 to $46.16. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $46.19 to $47.185. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $47.19 to $47.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $45.03 to $45.63. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $46.535 to $47.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP. Fully vested. /s/ Dorothy Pacini, Attorney-in-fact 2019-04-19